| 영문 | peptic ulcer | 한글 | 소화궤양 |
|---|---|---|---|
| 설명 | 산성 위액의 작용에 의해서 식도, 위 또는 샘창자 점막이 파괴되어 결손부가 생기는 것. 즉 위벽이 허는 것인데 단 그 원인이 산성위액에 의하였을 때 한하여 소화성 궤양이라 한다. 소화궤양은 위산에 의해서 발생한 궤양을 말한다. 소화궤양의 발생메커니즘은 기본으로 위-샘창자의 보호메커니즘과 손상요인의 불균형으로 발생한다. 소화궤양은 대개 긴지름 0.6cm 이상인 경우가 많고, 절반이상은 긴지름이 2cm 이상이다. 전통적으로 소화궤양은 둥근 모양에 경계가 분명하며 궤양의 벽은 반듯하다. 궤양의 가장자리는 악성 궤양과 달리 두꺼워져 있지 않다. |
||
| 영문 | peptide | 한글 | 펩티드 |
|---|---|---|---|
| 설명 | 두 개이상의 아미노산 분자 사이에서, 한쪽의 아미노기와 다른 쪽의 카르복실기가 물 분자를 잃으면서 축합하여 이루는 아미드 결합아미노산의 수가 2, 3, … 인 경우, 각각 디펩티드, 트리펩티드, …등으로 부르며, 여러 개의 아미노산으로 구성되는 것을 올리고펩티드, 이보다 큰 것을 폴리펩티드라고 한다. 직쇄상의 것이 많지만, 환상 구조를 갖는 펩티드도 있다. 저분자의 펩티드는 물, 산, 알칼리 따위에 잘 녹고 알코올에는 녹지 않으나, 고분자의 펩티드는 물에 잘 녹지 않고 단백질과 성질이 비슷하다. 뇌하수체호르몬, 브라디키닌 등과 같이 생리적기능이 현저한 것은 생리활성펩티드(bioactive peptide)라고 한다. |
||
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
|---|---|
| PU | palindromic unit; passed urine; pepsin unit; peptic ulcer; pregnancy urine; 6-propyluracil; prostati... |
| PUD | peptic ulcer disease; pudendal |
| C-Peptide | Connecting Peptide |
| ERP | early receptor potential; effective refractory period; elodoisin-related peptide; endoscopic retrogr... |
| PU | Peptic ulcer |
|---|---|
| PUD | Peptic ulcer disease |
| C-peptide | connecting peptide |
| LAP | 1-latency associated peptide |
| GLP-1 | 1.Glucagon-like peptide-1 amide |
corticotropin-releasing factor (부신 피질 호르몬 유리 요소, 부신 피질 호르몬 유리 인자
| Palmer acid test for peptic ulcer | In duodenal ulcer, the administration of acid by duodenal tube causes severe pain. (05 Mar 2000) |
|---|---|
| peptic | Pertaining to pepsin or to digestion, related to the action of gastric juices. Origin: Gr. Peptikos (18 Nov 1997) |
| peptic cell | <pathology> Cells of the basal part of the gastric glands of the stomach. They contain extensive rough endoplasmic reticulum and zymogen granules and secrete pepsinogen, the inactive precursor of pepsin and rennin. (18 Nov 1997) |
| peptic digestion | That part of digestion, chiefly of the proteins, carried on in the stomach by the enzymes of the gastric juice. Synonym: peptic digestion. (05 Mar 2000) |
| peptic gland | A pepsin-secreting gland. See: gastric glands. (05 Mar 2000) |
| peptic ulcer | <gastroenterology> An ulcer in the wall of the stomach or duodenum resulting from the digestive action of the gastric juice on the mucous membrane when the latter is rendered susceptible to its action. (13 Nov 1997) |
| peptic ulcer perforation | Penetration of a peptic ulcer through the stomach wall. May be free, i.e., at a point where the stomach wall faces a real or potential space,, or confined, i.e., at a point where the stomach wall is defended by contiguous or adjacent structures, such as the pancreas. (12 Dec 1998) |
| oesophagitis, peptic | Inflammation of the oesophagus caused by reflux of gastric juice and/or stomach and duodenal contents. (12 Dec 1998) |
| ulcer, peptic | A peptic ulcer is a hole in the lining of the stomach, duodenum, or oesophagus. A peptic ulcer of the stomach is called a gastric ulcer, an ulcer of the duodenum is a duodenal ulcer, and a peptic ulcer of the oesophagus is an oesophageal ulcer. A peptic ulcer occurs when the lining of these organs is corroded by the acidic digestive juices which are secreted by the stomach cells. Peptic ulcer disease is common, affecting millions of americans yearly. The medical cost of treating peptic ulcer and its complications runs in the billions of dollars annually in the u.s. Recent medical advances have increased our understanding of ulcer formation. Improved and expanded treatment options are now available. (12 Dec 1998) |
| alpha-aminoacyl-peptide hydrolases | <enzyme> Registry number: EC 3.4.11. (12 Dec 1998) |
| anionic neutrophil activating peptide | <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Acronym: IL-8 (12 Dec 1998) |
| antibiotics, peptide | Antibiotics whose structure contains one or more peptides, usually cyclic. They are generally effective against gram-positive bacteria and act by inhibiting peptidoglycan synthesis in bacterial cell walls. (12 Dec 1998) |
| atrial natriuretic peptide | <hormone> This cardiac hormone (28 amino acid residues) regulates salt and water balance in body fluids and blood pressure, it has potential as a medication to treat heart and kidney failure and the buildup of excess fluid in tissue. (09 Oct 1997) |
| bradykinin-potentiating peptide | <chemical> 2-l-tryptophan-3-de-l-leucine-4-de-l-proline-8-l-glutamine bradykinin potentiator b. A synthetic nonapeptide with the sequence pyr-trp-pro-arg-pro-gln-ile-pro-pro, which is identical to that of the peptide from the venom of the snake, bothrops jararaca. It acts as an inhibitor of kininase II and angiotensin I and has been proposed as an antihypertensive agent. Pharmacological action: angiotensin-converting enzyme inhibitors, antihypertensive agents. Chemical name: Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine- (12 Dec 1998) |
| brain natriuretic peptide | <hormone, protein> Brain peptide that induces diuresis, related to atrial natriuretic peptide. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|